149 related articles for article (PubMed ID: 30471710)
1. Effect of Cardiac Resynchronization Therapy on Left Ventricular Remodeling in Patients With Cardiac Sarcoidosis.
Patel D; Trulock KM; Toro S; Grimaldi A; Gonzalez M; Moennich LA; Gorodeski EZ; Joyce E; Niebauer M; Wilkoff BL; Varma N; Rickard JW
Am J Cardiol; 2019 Jan; 123(2):329-333. PubMed ID: 30471710
[TBL] [Abstract][Full Text] [Related]
2. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
3. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Patients With Cardiac Sarcoidosis Who Received Cardiac Resynchronization Therapy: Comparison With Dilated Cardiomyopathy Patients.
Yufu K; Kondo H; Shinohara T; Kawano K; Ishii Y; Miyoshi M; Imamura T; Saito S; Okada N; Akioka H; Teshima Y; Nakagawa M; Takahashi N
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):177-181. PubMed ID: 27862596
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy response in cardiac sarcoidosis.
Shabtaie SA; Sehrawat O; Lee JZ; Cha YM; Mulpuru SK; Kowlgi NG; Siontis KC; Rosenbaum AN; Bois JP; AbouEzzeddine OF; Noseworthy PA; Asirvatham SJ; DeSimone CV; Deshmukh AJ
J Cardiovasc Electrophysiol; 2022 Sep; 33(9):2072-2080. PubMed ID: 35870183
[TBL] [Abstract][Full Text] [Related]
6. [Influence of cardiopathy etiology on responses to cardiac resynchronization therapy].
Vidal B; Sitges M; Delgado V; Mont L; Díaz-Infante E; Azqueta M; Paré C; Tolosana JM; Berruezo A; Tamborero D; Roig E; Brugada J
Rev Esp Cardiol; 2007 Dec; 60(12):1264-71. PubMed ID: 18082092
[TBL] [Abstract][Full Text] [Related]
7. Left ventricle and mitral valve reverse remodeling in response to cardiac resynchronization therapy in nonischemic cardiomyopathy.
Mihos CG; Yucel E; Upadhyay GA; Orencole MP; Singh JP; Picard MH
Echocardiography; 2020 Oct; 37(10):1557-1565. PubMed ID: 32914427
[TBL] [Abstract][Full Text] [Related]
8. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation.
Mihos CG; Yucel E; Capoulade R; Orencole MP; Upadhyay GA; Santana O; Singh JP; Picard MH
Echocardiography; 2017 Nov; 34(11):1561-1567. PubMed ID: 28895197
[TBL] [Abstract][Full Text] [Related]
9. Women with nonischemic cardiomyopathy have a favorable prognosis and a better left ventricular remodeling than men after cardiac resynchronization therapy.
Cipriani M; Landolina M; Oliva F; Ghio S; Vargiu S; Rordorf R; Raineri C; Ammirati E; Petracci B; Campo C; Bisetti S; Lunati M
J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):291-8. PubMed ID: 25222077
[TBL] [Abstract][Full Text] [Related]
10. Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.
Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Shimizu W
Heart Rhythm; 2014 May; 11(5):836-41. PubMed ID: 24561161
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Sarcoidosis, Left Ventricular Impairment and Chronic Right Ventricular Pacing: Pacing or Pathology?
Forotan H; Rowe MK; Korczyk D; Kaye G
Heart Lung Circ; 2017 Nov; 26(11):1175-1182. PubMed ID: 28652030
[TBL] [Abstract][Full Text] [Related]
12. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy.
Patel D; Kumar A; Moennich LA; Trulock K; Nemer DM; Donnellan E; Il'Giovine ZJ; Martyn T; Callahan TD; Hussein AA; Tarakji KG; Kanj M; Cantillon DJ; Baranowski B; Starling RC; Tang WHW; Wazni OM; Varma N; Wilkoff BL; Rickard J
Heart; 2022 Feb; 108(4):274-278. PubMed ID: 34489312
[TBL] [Abstract][Full Text] [Related]
15. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.
Soliman OI; Geleijnse ML; Theuns DA; Nemes A; Vletter WB; van Dalen BM; Motawea AK; Jordaens LJ; ten Cate FJ
Am J Cardiol; 2008 Mar; 101(5):651-7. PubMed ID: 18308015
[TBL] [Abstract][Full Text] [Related]
16. Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study.
Biffi M; Defaye P; Jaïs P; Ruffa F; Leclercq C; Gras D; Yang Z; Gerritse B; Ziacchi M; Morgan JM;
Int J Cardiol; 2018 May; 259():88-93. PubMed ID: 29579617
[TBL] [Abstract][Full Text] [Related]
17. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling.
Auricchio A; Schillinger W; Meyer S; Maisano F; Hoffmann R; Ussia GP; Pedrazzini GB; van der Heyden J; Fratini S; Klersy C; Komtebedde J; Franzen O;
J Am Coll Cardiol; 2011 Nov; 58(21):2183-9. PubMed ID: 22078424
[TBL] [Abstract][Full Text] [Related]
18. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
19. Cardiac resynchronization therapy for patients with cardiac sarcoidosis.
Sairaku A; Yoshida Y; Nakano Y; Hirayama H; Maeda M; Hashimoto H; Kihara Y
Europace; 2017 May; 19(5):824-830. PubMed ID: 28339577
[TBL] [Abstract][Full Text] [Related]
20. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study.
Wang NC; Li JZ; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S
Pacing Clin Electrophysiol; 2018 Feb; 41(2):143-154. PubMed ID: 29314085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
